|
abatacept |
|---|---|
| Trade Name | Orencia |
| Orphan Indication | Graft Versus Host Disease |
| USA Market Approval | USA |
| USA Designation Date | 2017-12-26 00:00:00 |
| Sponsor | Bristol-Myers Squibb Co.;P.O Box 4000;Princeton, New Jersey, 08543 |
|
abatacept |
|---|---|
| Trade Name | Orencia |
| Orphan Indication | Graft Versus Host Disease |
| USA Market Approval | USA |
| USA Designation Date | 2017-12-26 00:00:00 |
| Sponsor | Bristol-Myers Squibb Co.;P.O Box 4000;Princeton, New Jersey, 08543 |